Ensysce Biosciences Inc. (ENSC)
NASDAQ · Healthcare
Ensysce Biosciences Inc. Total Liabilities 2020–2025
Ensysce Biosciences Inc. annual total liabilities history from 2020 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Ensysce Biosciences Inc. total liabilities as of December 31, 2025: 4.6M, a 106.00% increase year-over-year.
- Ensysce Biosciences Inc. total liabilities for 2025 were 4.6M, a 106.00% increase from 2024.
- Ensysce Biosciences Inc. total liabilities for 2024 were 2.2M, a 34.00% decrease from 2023.
- Ensysce Biosciences Inc. total liabilities for 2023 were 3.4M, a 66.12% decrease from 2022.
- Ensysce Biosciences Inc. total liabilities for 2022 were 9.9M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Ensysce Biosciences Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $5 |
| 2024 | $2 |
| 2023 | $3 |
| 2022 | $10 |
| 2021 | $25 |
| 2020 | $7 |
Ensysce Biosciences Inc. Total Liabilities — FAQ
Ensysce Biosciences Inc. (ENSC) total liabilities over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ENSC's total liabilities history?
The chart and table above show Ensysce Biosciences Inc.'s total liabilities by year and by quarter, including the growth rate.